<DOC>
	<DOC>NCT02294539</DOC>
	<brief_summary>The purpose of this study is to investigate which combination therapy is more effective for improving the blood pressure (BP) and AM central SBP in hypertensive patients:Angiotensin II receptor blocker (ARB) plus calcium channel blocker (CCB) or ARB plus diuretics</brief_summary>
	<brief_title>Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Calcium Channel Blockers</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<criteria>Hypertension patients not included exclusion criteria Mean seated SBP ≥140mmHg in patients with newly Diagnosed msDBP≥110mmHg or ms SBP ≥ 180mmHg at the screening and randomization visit</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>